Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Eliot N. Mostow MD, MPH Associate Editor

Sarah L. Chamlin MD Advisory Board

See All Experts

Published in Dermatology

Journal Scan / Research · December 02, 2024

Outcomes of Ruxolitinib Cream Monotherapy in Adults and Adolescents With Mild to Moderate Atopic Dermatitis

American Journal of Clinical Dermatology

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Additional Info

Article Citation

American Journal of Clinical Dermatology

Ruxolitinib Cream Monotherapy Improved Symptoms and Quality of Life in Adults and Adolescents with Mild-to-Moderate Atopic Dermatitis: Patient-Reported Outcomes from Two Phase III Studies

Am J Clin Dermatol 2024 Nov 15;[EPub Ahead of Print], EL Simpson, M Augustin, D Thaçi, L Misery, AW Armstrong, A Blauvelt, KA Papp, JC Szepietowski, M Boguniewicz, SG Kwatra, H Kallender, D Sturm, H Ren, L Kircik

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Outcomes of Ruxolitinib Cream Monotherapy in Adults and Adolescents With Mild to Moderate Atopic Dermatitis

Additional Info

Ruxolitinib Cream Monotherapy Improved Symptoms and Quality of Life in Adults and Adolescents with Mild-to-Moderate Atopic Dermatitis: Patient-Reported Outcomes from Two Phase III Studies

Further Reading

Outcomes of Using Wound Closure Techniques After Wide Excision of Hidradenitis Suppurativa Lesions

Rebound Growth of Infantile Hemangiomas After Discontinuation of Treatment With Propranolol vs Atenolol

Allergic Contact Cheilitis/Stomatitis Owing to Beverages and Food

Assessing Skin Cancer Diagnosis Accuracy by Lesion Type, Physician Experience, and Examination Method

Doxycycline Post-Exposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention

Association Between 5α-Reductase Inhibitor Use for Dermatologic Conditions and the Risk of Breast or Gynecologic Cancers

Efficacy of Treatment With Secukinumab in Patients With Hidradenitis Suppurativa

Local Recurrence, Metastasis, and Mortality Rates Among Patients With Thin and In Situ Melanomas

Suicidal and Self-Injurious Behaviors Among Patients With Psoriasis or Psoriatic Arthritis Treated With Biologics

Efficacy and Safety of Combined Topical 17α-Ethinyl Estradiol With Minoxidil vs Topical Minoxidil Alone in Patients With Female Pattern Hair Loss

Clinical Features and Treatment Outcomes Among Patients With Primary Cutaneous B-Cell Lymphomas

Recently Updated